Pt-Mal-LHRH showed a significant attenuation in tumor growth compared to carboplatin and normal control growth (saline), with the largest attenuation found with Pt-Mal-LHRH 20mg/kg treatment (Fig 2A). The gene discussed is GNRH1; the disease is neoplasm.